Seed Co., Ltd. (JP:7743)
:7743
Want to see JP:7743 full AI Analyst Report?
7743 Stock Chart & Stats
¥575.00
¥8.00(1.52%)
At close: 4:00 PM EST
¥575.00
¥8.00(1.52%)
Day’s Range― - ―
52-Week Range¥445.00 - ¥659.00
Previous CloseN/A
Volume444.10K
Average Volume (3M)68.49K
Market Cap
¥14.59B
Enterprise Value¥39.43B
Total Cash (Recent Filing)¥4.21B
Total Debt (Recent Filing)¥28.47B
Price to Earnings (P/E)12.8
Beta0.58
Next Earnings
Aug 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.65%
Share Statistics
EPS (TTM)37.50
Shares Outstanding30,265,923
10 Day Avg. Volume58,390
30 Day Avg. Volume68,493
Financial Highlights & Ratios
PEG Ratio4.17
Price to Book (P/B)0.95
Price to Sales (P/S)0.54
P/FCF Ratio-41.87
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)34
Revenue Forecast (FY)¥36.00B
Bulls Say, Bears Say
Bulls Say
Recurring, Repeat-purchase RevenueSeed's core product set—disposable and replacement contact lenses—creates predictable, recurring purchase cycles and built-in customer replenishment. That structural demand supports steady top-line visibility, inventory turns, and long-term customer value that underpin revenue resilience over months.
Steady Revenue Growth 2024–2026Consistent year-to-year revenue expansion indicates stable product demand and market position in core eye-care categories. Even with moderating growth rates, this trend supports ongoing scale benefits and planning reliability for production and distribution over the coming 2–6 months.
Improved Gross Margin Vs 2023A meaningful gross margin improvement versus 2023 suggests better pricing, cost control, or a more favorable product mix. Sustainable margin gains bolster operating leverage, making future earnings less sensitive to revenue swings and improving the ability to invest in product or distribution.
Bears Say
Negative Free Cash Flow In 2025–2026Two consecutive years of negative free cash flow indicate the business is consuming cash despite positive operating cash flow, likely from heavy investment or working-capital strain. This reduces financial flexibility to fund growth, pay down debt, or sustain payouts over the medium term.
Elevated Leverage (~1.48x Debt/equity)Material leverage at roughly 1.4–1.5x equity constrains balance-sheet flexibility. With debt rising in absolute terms and only modest ROE, higher leverage increases refinancing and interest risk, limiting the company's ability to invest or withstand demand shocks over the next several quarters.
Volatile Profitability; Compressed Operating MarginsLarge swings in net margin and compressed operating profits point to inconsistent pricing power, cost pressures, or mix shifts. That volatility undermines forecasting accuracy, weakens return stability, and increases execution risk for sustaining investments or servicing debt over the medium term.
Seed Co., Ltd. News
7743 FAQ
What was Seed Co., Ltd.’s price range in the past 12 months?
Seed Co., Ltd. lowest stock price was ¥445.00 and its highest was ¥659.00 in the past 12 months.
What is Seed Co., Ltd.’s market cap?
Seed Co., Ltd.’s market cap is ¥14.59B.
When is Seed Co., Ltd.’s upcoming earnings report date?
Seed Co., Ltd.’s upcoming earnings report date is Aug 12, 2026 which is in 62 days.
How were Seed Co., Ltd.’s earnings last quarter?
Seed Co., Ltd. released its earnings results on May 11, 2026. The company reported ¥7.59 earnings per share for the quarter, beating the consensus estimate of N/A by ¥7.59.
Is Seed Co., Ltd. overvalued?
According to Wall Street analysts Seed Co., Ltd.’s price is currently Overvalued.
Does Seed Co., Ltd. pay dividends?
Seed Co., Ltd. pays a Annually dividend of ¥15 which represents an annual dividend yield of 2.65%. See more information on Seed Co., Ltd. dividends here
What is Seed Co., Ltd.’s EPS estimate?
Seed Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Seed Co., Ltd. have?
Seed Co., Ltd. has 30,265,923 shares outstanding.
What happened to Seed Co., Ltd.’s price movement after its last earnings report?
Seed Co., Ltd. reported an EPS of ¥7.59 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.284%.
Which hedge fund is a major shareholder of Seed Co., Ltd.?
Currently, no hedge funds are holding shares in JP:7743
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Seed Co., Ltd.
SEED Co.,Ltd. is an international manufacturer and supplier specializing in a broad spectrum of ophthalmic products. The company's extensive range includes various contact lenses, lens care solutions, fashionable spectacle frames, and other vision enhancement items, serving customers in Japan and across global markets. Their diverse contact lens collection features numerous daily disposable options, such as the SEED 1dayPure moisture, SEED Eye coffret 1day UV, SEED 1dayPure EDOF, SEED PlusMode 1day Homme, and JILL STUART 1day UV. They also offer specialized daily lenses, including multistage and astigmatism-correcting versions like the SEED 1dayPure moisture for astigmatism. Furthermore, SEED provides two-week disposable lenses through its SEED 2weekPure moisture series, which encompasses standard, multistage bifocal, and astigmatism-specific variants. Monthly replacement lenses, such as SEED MonthlyFine UV and monthly color lens UV, are also part of their portfolio, alongside advanced rigid gas permeable and medical contact lenses. In addition to vision correction products, SEED Co.,Ltd. designs and sells eyewear frames under well-known brands like Vivid Moon, ViVi fleurs, and Plusmix. The company also develops pharmaceutical products, including Adeno Test AD for the detection of adenovirus antigens, and other solutions aimed at improving visual health. Established in 1957, SEED Co.,Ltd. is based in Tokyo, Japan.
Technical Analysis
JINS HOLDINGS
―
Menicon Co
―
Ship Healthcare Holdings
―
Japan Eyewear Holdings Co.,Ltd.
―
Mani, Inc.
―
Options Prices
Currently, No data available
---